Reported Consolidated quarterly numbers for Panacea Biotec are:Net Sales at Rs 182.02 crore in September 2020 up 45.41% from Rs. 125.18 crore in September 2019.
Quarterly Net Loss at Rs. 19.33 crore in September 2020 up 74.23% from Rs. 75.00 crore in September 2019.
EBITDA stands at Rs. 40.01 crore in September 2020 up 1669.02% from Rs. 2.55 crore in September 2019.
Panacea Biotec shares closed at 239.00 on January 04, 2021 (NSE) and has given 21.66% returns over the last 6 months and 83.78% over the last 12 months.
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'20 | Jun'20 | Sep'19 | | Net Sales/Income from operations | 182.02 | 132.76 | 125.18 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 182.02 | 132.76 | 125.18 | | EXPENDITURE | | Consumption of Raw Materials | 49.10 | 37.76 | 55.92 | | Purchase of Traded Goods | 3.67 | 1.82 | 2.68 | | Increase/Decrease in Stocks | 11.03 | -0.14 | -21.71 | | Power & Fuel | -- | -- | -- | | Employees Cost | 37.52 | 35.10 | 35.48 | | Depreciation | 11.38 | 11.33 | 11.08 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 42.69 | 35.68 | 58.81 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 26.63 | 11.21 | -17.08 | | Other Income | 2.00 | 1.19 | 3.45 | | P/L Before Int., Excpt. Items & Tax | 28.63 | 12.40 | -13.63 | | Interest | 47.51 | 45.23 | 41.48 | | P/L Before Exceptional Items & Tax | -18.88 | -32.83 | -55.11 | | Exceptional Items | -- | -- | -15.39 | | P/L Before Tax | -18.88 | -32.83 | -70.50 | | Tax | 0.09 | 0.34 | 2.35 | | P/L After Tax from Ordinary Activities | -18.97 | -33.17 | -72.85 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -0.43 | -1.02 | -2.18 | | Net Profit/(Loss) For the Period | -19.40 | -34.19 | -75.03 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | 0.07 | 0.06 | 0.03 | | Net P/L After M.I & Associates | -19.33 | -34.13 | -75.00 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.09 | -5.41 | -12.25 | | Diluted EPS | -3.09 | -5.41 | -12.25 | | EPS After Extra Ordinary | | Basic EPS | -3.09 | -5.41 | -12.25 | | Diluted EPS | -3.09 | -5.41 | -12.25 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|